More than 400 COVID-19 patients take part in MFT research trials
MFT has recruited more than 400 patients to research trials in an attempt to better understand and treat COVID-19.
Read more
MFT has recruited more than 400 patients to research trials in an attempt to better understand and treat COVID-19.
Read more
In an unprecedented move, scientists and clinicians across Greater Manchester have formed a Rapid Response Research Group to find ways to beat COVID-19 and save lives.
Read more
Manchester researchers have discovered an association between the number of prescriptions for antibiotics and a higher risk of hospital admissions.
Read more
Two trials of a new drug have shown that, at low doses, it can ease the often-distressing symptoms of chronic cough with minimal side effects.
Read more
In the third blog in our ‘addressing health inequalities in research’ series, Information Data Management Lead, Gareth Adaway, discusses the role data plays in our work.
Read more
In the second blog in our ‘addressing health inequalities in research’ series, our Public Programmes Project Manager, Tracy Grey, discusses some of the health inequalities that persist in GM and why.
Read more
Manchester BRC researchers have launched the world’s first emergency genetic test, to predict whether newborn babies receiving antibiotics in intensive care are at risk of irreversible hearing loss.
Read more
In the first instalment in our new blog series, Dr Bella Starling – Co-Director of Public Programmes, hosted by MFT – discusses the benefits translational research can have for society as a whole.
Read more